Wave Life Sciences Ltd.
Clinical trials sponsored by Wave Life Sciences Ltd., explained in plain language.
-
New hope for rare lung and liver disease: experimental drug WVE-006 enters human testing
Disease control OngoingThis study tests an experimental drug called WVE-006 in 24 adults with a genetic condition called alpha-1 antitrypsin deficiency (AATD), which can damage the lungs and liver. The goal is to see if the drug is safe and how it moves through the body. Participants receive either a s…
Phase: PHASE1, PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 17, 2026 10:41 UTC
-
New hope for duchenne: Long-Term safety trial of WVE-N531 underway
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of an experimental drug called WVE-N531 in people with Duchenne muscular dystrophy who have already taken it in a previous study. About 175 participants will receive the drug and be monitored for side effects, heart and lung function, and …
Phase: PHASE2 • Sponsor: Wave Life Sciences Ltd. • Aim: Disease control
Last updated May 14, 2026 12:03 UTC